An expert panel of the Central Drugs Standard Control Organisation today recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2...
from NDTV News - Special https://ift.tt/2Wix9xG
via
No comments:
Post a Comment